Answers are grounded in this paper and cite their sources.
Obstructive sleep apnea (OSA) is an increasingly prevalent disorder associated with serious health risks. Although discussing treatment options with healthcare providers is recommended before initiating therapy, such shared decision making (SDM) is not yet widely practiced. Decision aids (DAs) are effective tools for facilitating SDM, but no DA has been developed for OSA treatment in Japan. This study aimed to develop a DA to help individuals newly diagnosed with OSA choose a treatment option consistent with their personal values and to evaluate its acceptability among both patients and healthcare providers. A DA was systematically developed in accordance with the International Patient Decision Aid Standards. First, a prototype was created on the basis of evidence from the 2020 Clinical Practice Guideline for Sleep Apnea Syndrome. Second, alpha acceptability testing was conducted via a mixed-methods questionnaire administered to patients and healthcare providers. Feedback, including free-text qualitative comments, was incorporated to refine the prototype and produce a final version suitable for clinical use. The 28-page DA consisted of a description of OSA; the available treatment options—(i) continuous positive airway pressure, (ii) oral appliance, (iii) weight loss, and (iv) side sleeping; the advantages and disadvantages of each option; and value clarification exercises for each option. Patients ( n = 18) reported that the DA had appropriately concise sentences (89%), adequate information (94%), and a well-balanced presentation (100%) and was useful in deciding which treatment option to choose for OSA (94%). Healthcare providers ( n = 21) also provided favourable feedback. On the basis of the acceptability assessment, the prototype was refined to produce a final version suitable for clinical use. A DA to support treatment choices for OSA, specifically developed for use during the SDM process, was successfully created. Further research is warranted to evaluate its impact on decision quality and patient outcomes.
No takes yet. Share an insight, caveat, or question.
Aoki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: